AMPE (Ampio Pharmaceuticals) Institutional Ownership: 0.01% (As of Jul. 04, 2026)


What is Ampio Pharmaceuticals Institutional Ownership?

Ampio Pharmaceuticals AMPE -71.39% Institutional Ownership is 0.01% as of Jul. 04, 2026.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Ampio Pharmaceuticals's institutional ownership is 0.01%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Ampio Pharmaceuticals's Insider Ownership is 30.67%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Ampio Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 0.00%.

Ampio Pharmaceuticals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Ampio Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ampio Pharmaceuticals Institutional Ownership Chart

Ampio Pharmaceuticals Historical Data

The historical data trend for Ampio Pharmaceuticals can be seen below:

2023-04-30 2023-05-31 2023-06-30 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31
Institutional Ownership 0.02 0.02 0.01 0.46 0.44 0.44 0.44 0.44 0.44 0.32

Ampio Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.01% mean?
Ampio Pharmaceuticals (AMPE) has a Institutional Ownership of 0.01% as of Jul. 04, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Ampio Pharmaceuticals and its competitors.
Is Ampio Pharmaceuticals' Institutional Ownership too high?
Ampio Pharmaceuticals' current Institutional Ownership is 0.01%.
How does Ampio Pharmaceuticals' Institutional Ownership compare to EFTR and VBIVQ?
Ampio Pharmaceuticals' Institutional Ownership of 0.01% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Ampio Pharmaceuticals and its competitors. Ampio Pharmaceuticals's current Institutional Ownership is 0.01%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ampio Pharmaceuticals stock overvalued right now?
Ampio Pharmaceuticals (AMPE) has a current Institutional Ownership of 0.01%. The current Institutional Ownership is 0.01%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Ampio Pharmaceuticals (AMPE), the current Institutional Ownership is 0.01% as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ampio Pharmaceuticals Business Description

Address 9800 Mount Pyramid Court, Suite 400, Englewood, CO, USA, 80112
Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development of a potential treatment for osteoarthritis of the knee (OAK) as part of its OA-201 development program (OA-201 program or OA-201).